glp-1 and blood clots Do Drugs Cause Clots? Evidence Guidance GLP-1 meds might reduce blood
Description
This accessibility gap is the most immediate factor for most researchers choosing between the two
References: Montero A et al
Because the patient has not yet been approved, the claim would be expected to reject or deny
Retatrutide is currently in Phase 3 clinical trials and has not yet received FDA approval
